Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

InControl makes first atrial defibrillator implant:

This article was originally published in Clinica

Executive Summary

The first human implant of InControl's (US) Metrix atrial defibrillator was undertaken in London at the end of October. This is the first time an implantable defibrillator has been used for upper chamber therapy. InControl has tested the device in 17 humans, in four US electrophysiology laboratories since July, and plans to file an IDE for US implant trials in the next few months. Around four million people in the US and Europe suffer from atrial fibrillation and the American Heart Association estimates that more than 75,000 strokes a year in the US are associated with the rhythm disorder.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094073

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel